Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc. (INO) — Form SCHEDULE 13G: Ownership over 5% (passive)

SC 13GINOFiled Aug 7, 2026, 12:13 PM ET

About this filing

Inovio Pharmaceuticals Inc. (INO) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Aug 7, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More INO filings

8-K
Current report
Filed Oct 6, 2026
8-K
Current report
Filed Aug 12, 2026
10-Q
Quarterly report
Filed Aug 12, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Aug 12, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Aug 6, 2026
SC 13G
Ownership over 5% (passive)
Filed Jul 31, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.